Trials / Completed
CompletedNCT05966753
Describing Patient With DME, Their Patient Journey and Disease Progression
Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 221,004 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.
Conditions
Timeline
- Start date
- 2023-08-03
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2023-08-01
- Last updated
- 2024-12-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05966753. Inclusion in this directory is not an endorsement.